By merging the outcomes derived from the BMI values and the different breast cancer histological types, it was found that in IDC cases, the VEGF and HB-EGF serum levels were augmented in overweight/obese patients when compared to those of patients with a BMI < 25 kg/ m2. This evidence concerns the gene VEGFA and breast cancer.